46. Chipps, B.E. Letter to the Editor, Systemic Reaction to Omalizumab. Ann Allergy Asthma Immunol. 2006;97:267. View

45. Chipps, B.E., Spahn, J.D., Sorkness, C.A., Baitnger, L., Sutton, L.B., Emmett, A.H., Dorinsky, P.M. Variability in Asthma Severity in Pediatric Subjects with Asthma Previously Receiving Short-Acting B2-Agonists. J Pediatr. 2006;148:517-21. View

44. Sander, N., Fusco-Walker, S.J., McElvain, J., Chipps, B.E. Running on Empty: The Need for Dose counters on Pressurized Metered-Dose Inhalers. Ann Allergy Asthma Immunol. 2006;97:34-38. View

43. Spahn, J.D., Chipps, B.E., Office-based objective measures of lung function in childhood asthma. J Pediatr, 2006; 148: 11-15. View

42. Chipps, B.E., Haselkorn, T., Lee, J.H., Miller,
D.P., Wenzel, S.E., Gender Differences in IgE-Mediated Allergic
Asthma in the Epidemiology and Natural History of Asthma: Outcomes
and Treatment Regimens (TENOR) Study. Journal of Asthma, 2006; 43:179-184. View

41. Borish, L. Chipps, B.E., Deniz, Y., Zheng, B., Dolan, C., Total Serum IgE levels in a large cohort of subjects with severe or difficult to treat asthma. Ann Allergy Asthma Immunol.
2005;95:247-253 View

40. Chipps, B.E., Murphy, K.M., Assessment and Treatment of Acute Asthma in Children. J Pediatr 2005; 147:288-94. View

39. Chipps, B.E., Determinants of asthma and its clinical course. Ann Allergy Asthma Immunol. 2004;93:309-316 View

38. Chipps, B.E., Marshik, P.L., Targeted IgE Therapy for Patients With Moderate to Severe Asthma. Biotechnology Healthcare -July/August 2004;56-61. View